Two new drug treatments for variant CJD, the human version of mad cow
disease, will be tested in Britain. A team led by Carsten Korth and Stanley
Prusiner at the University of California, San Francisco, has found that both
drugs—already used to treat malaria and schizophrenia—halt the
progress of the disease in cell culture. A 20-year-old British woman with vCJD
is reported to have shown marked improvement following treatment, but a second
patient is said to be no better. The Department of ÎçÒ¹¸£Àû1000¼¯ºÏ says the drugs could
be tested on seven British vCJD patients as soon as trials…
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Environment
2026 will be the hottest year on record, leading scientist predicts
News
Technology
NHS England rushes to hide software over AI hacking fears
News
ÎçÒ¹¸£Àû1000¼¯ºÏ
The 4 biggest myths about hydration, according to an expert
Comment
Life
Oak trees use delaying tactics to thwart hungry caterpillars
News
Popular articles
Trending New Scientist articles
1
We have figured out a new way to send messages into the past
2
Human heads have changed shape a lot in the past 100 years
3
100-year-old assumption about the universe may soon be overturned
4
Why the keto diet could be a revolutionary way to treat mental illness
5
Thought-provoking photographs capture what it feels like to have ADHD
6
Is consciousness more fundamental to reality than quantum physics?
7
The 4 biggest myths about hydration, according to an expert
8
Weird 'transdimensional' state of matter is neither 2D nor 3D
9
Surprising male G-spot found in most detailed study of the penis yet
10
What to read this week: The 21st Century Brain by Hannah Critchlow
